Cooper Companies (COO) Stock Price & Analysis

COO$62.65+0.46 +0.74%
Medical - Instruments & SuppliesLarge CapValue Stock
Compare
Market cap$11.91BEnterprise value$14.22BRevenue (TTM)$4.24BMarket positionTop 25%

Score

53
Neutral
Value
71
Quality
40
Growth
48

AI Analysis

Snapshot

The Cooper Companies is primarily a valuation case — Value 71/100 at P/E 21.2 — with the overall score at 53/100. Under the hood: P/E 21.2, plus revenue compounding ~7% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

71
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

48
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

40
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

The Cooper Companies, Inc. (COO) last printed $62.65. Equity value is $11.91B. Trailing earnings multiple 20.89. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$1.97B$2.14B$2.53B$2.65B$2.43B$2.92B$3.31B$3.59B$3.9B$4.09B

About

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Cooper Companies (COO) Stock Price & Analysis

COO price $62.65 +0.46 +0.74%

Ticker
COO
Price
$62.65
Change
+0.46 +0.74%
Market cap
$11.91B
P/E
20.89
Forward P/E
13.50
Dividend yield
0.00%
Beta
0.82
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
53
Value
71
Quality
40
Growth
48

Stocklytics score rationale: value 71, quality 40, growth 48.

AI Score 75. The Cooper Companies, Inc. (COO) has a solid market cap of approximately $12.25 billion and a healthy gross profit margin of about 63.6%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener